Skip to main content
Jemperli 50 mg/mL injection by GlaxoSmithKline LLC
Jemperli, 50 mg/mL, injection Drug class: Programmed Death Receptor-1 Blocking Antibody. Available on prescription only. Listed by GlaxoSmithKline LLC.
Prescription only

Jemperli

dostarlimab

Listed by GlaxoSmithKline LLC

Strength
50 mg/mL
Form
Injection
Route
Intravenous
Class
Programmed Death Receptor-1 Blocking Antibody

What it contains

  • Dostarlimab 50 mg/mL

FDA record

Dosage form Injection
Route Intravenous
Drug class Programmed Death Receptor-1 Blocking Antibody
Approval route BLA — biologic licence
NDC code 0173-0898
FDA application BLA761174
RxNorm concept 2539972
Package sizes listed 1
Marketed since April 2021

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.